Developing a Noninvasive Procedure Using Labeled Monoclonal Antibody Anti-VEGF (Bevacizumab) for Detection of Endometriosis

Figure 1

Biodistribution of bevacizumab labeled with 99mTc after 1 hour injection. This is the mean of 15 rats.